How to Profit from Compound Management Know-How?
Pharmaceuticals & Biotechnology Editor | 09/14/2011
Oliver Peter, PhD, Group Head of Drug Discovery Biology at HTS Group, Actelion Pharmaceuticals, joins Pharma IQ, to discuss compounds and biosamples and materials management.In this interview Peter covers biosample stabilisation, optimum data structures to store biosample information, challenges associated with low temperature storage and how to profit from compound management know-how.
To continue reading this story Click Here